タイトル | How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study UsingN-Myristoyltransferases as a Model System. |
---|
ジャーナル・号・ページ | J. Med. Chem., Year 2019 |
---|
掲載日 | 2017年10月27日 (構造データの登録日) |
---|
著者 | Kersten, C. / Fleischer, E. / Kehrein, J. / Borek, C. / Jaenicke, E. / Sotriffer, C. / Brenk, R. |
---|
リンク | J. Med. Chem. / PubMed:31423787 |
---|
手法 | X線回折 |
---|
解像度 | 1.49608302465 - 2.05 Å |
---|
構造データ | PDB-6eu5: Leishmania major N-myristoyltransferase with bound myristoyl-CoA and inhibitor 手法: X-RAY DIFFRACTION / 解像度: 1.49608302465 Å PDB-6ewf: Leishmania major N-myristoyltransferase with bound myristoyl-CoA and inhibitor 手法: X-RAY DIFFRACTION / 解像度: 1.53517331196 Å PDB-6f56: Mutant of Human N-myristoyltransferase with bound myristoyl-CoA 手法: X-RAY DIFFRACTION / 解像度: 1.9401987668 Å PDB-6fz2: Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound 手法: X-RAY DIFFRACTION / 解像度: 2.05 Å PDB-6fz3: Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound 手法: X-RAY DIFFRACTION / 解像度: 2 Å PDB-6fz5: Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound 手法: X-RAY DIFFRACTION / 解像度: 1.89 Å |
---|
化合物 | ChemComp-BXN: 4-[3-[(8~{a}~{R})-3,4,6,7,8,8~{a}-hexahydro-1~{H}-pyrrolo[1,2-a]pyrazin-2-yl]propyl]-2,6-bis(chloranyl)-~{N}-methyl-~{N}-(1,3,5-trimethylpyrazol-4-yl)benzenesulfonamide
ChemComp-31A: N-[2-(3-methoxyphenyl)ethanimidoyl]-2-piperidin-4-yloxy-benzamide
ChemComp-EBK: 2,6-bis(chloranyl)-4-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]-~{N}-(1,3,5-trimethylpyrazol-4-yl)benzenesulfonamide
|
---|
由来 | - leishmania major (大形リーシュマニア)
- homo sapiens (ヒト)
|
---|
キーワード | TRANSFERASE / N-Myristoyltransferase / selective inhibitor / parasite / mutant / protein-ligand complex |
---|